353 related articles for article (PubMed ID: 18611116)
1. Structure-ADME relationship: still a long way to go?
Hou T; Wang J
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
[TBL] [Abstract][Full Text] [Related]
2. In silico ADME prediction: data, models, facts and myths.
Lombardo F; Gifford E; Shalaeva MY
Mini Rev Med Chem; 2003 Dec; 3(8):861-75. PubMed ID: 14529504
[TBL] [Abstract][Full Text] [Related]
3. Recent developments of in silico predictions of intestinal absorption and oral bioavailability.
Hou T; Li Y; Zhang W; Wang J
Comb Chem High Throughput Screen; 2009 Jun; 12(5):497-506. PubMed ID: 19519329
[TBL] [Abstract][Full Text] [Related]
4. truPK -- human pharmacokinetic models for quantitative ADME prediction.
Subramanian K
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461
[TBL] [Abstract][Full Text] [Related]
5. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.
Moda TL; Torres LG; Carrara AE; Andricopulo AD
Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738
[TBL] [Abstract][Full Text] [Related]
6. Computational modeling of human oral bioavailability: what will be next?
Cabrera-Pérez MÁ; Pham-The H
Expert Opin Drug Discov; 2018 Jun; 13(6):509-521. PubMed ID: 29663836
[TBL] [Abstract][Full Text] [Related]
7. In silico predictions of ADME-Tox properties: drug absorption.
Geerts T; Vander Heyden Y
Comb Chem High Throughput Screen; 2011 Jun; 14(5):339-61. PubMed ID: 21470183
[TBL] [Abstract][Full Text] [Related]
8. Development of predictive pharmacokinetic simulation models for drug discovery.
Norris DA; Leesman GD; Sinko PJ; Grass GM
J Control Release; 2000 Mar; 65(1-2):55-62. PubMed ID: 10699270
[TBL] [Abstract][Full Text] [Related]
9. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
10. Recent developments of in silico predictions of oral bioavailability.
Zhu J; Wang J; Yu H; Li Y; Hou T
Comb Chem High Throughput Screen; 2011 Jun; 14(5):362-74. PubMed ID: 21470180
[TBL] [Abstract][Full Text] [Related]
11. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
Khakar PS
Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
[TBL] [Abstract][Full Text] [Related]
12. [Recent advance in predicting oral bioavailability].
Ma GL; Cheng YY
Yao Xue Xue Bao; 2006 Oct; 41(10):917-20. PubMed ID: 17184106
[No Abstract] [Full Text] [Related]
13. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
[TBL] [Abstract][Full Text] [Related]
14. In silico ADME/Tox: the state of the art.
Ekins S; Rose J
J Mol Graph Model; 2002 Jan; 20(4):305-9. PubMed ID: 11858639
[TBL] [Abstract][Full Text] [Related]
15. Hologram QSAR model for the prediction of human oral bioavailability.
Moda TL; Montanari CA; Andricopulo AD
Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
[TBL] [Abstract][Full Text] [Related]
16. ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans.
Klopman G; Stefan LR; Saiakhov RD
Eur J Pharm Sci; 2002 Dec; 17(4-5):253-63. PubMed ID: 12453615
[TBL] [Abstract][Full Text] [Related]
17. Advances in computationally modeling human oral bioavailability.
Wang J; Hou T
Adv Drug Deliv Rev; 2015 Jun; 86():11-6. PubMed ID: 25582307
[TBL] [Abstract][Full Text] [Related]
18. Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds.
Zhang T; Heimbach T; Lin W; Zhang J; He H
J Pharm Sci; 2015 Sep; 104(9):2795-806. PubMed ID: 25690565
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
Paixão P; Gouveia LF; Morais JA
Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
[TBL] [Abstract][Full Text] [Related]
20. Gaussian processes: a method for automatic QSAR modeling of ADME properties.
Obrezanova O; Csanyi G; Gola JM; Segall MD
J Chem Inf Model; 2007; 47(5):1847-57. PubMed ID: 17602549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
